Treatment-resistant depression and major depression with suicide risk-The cost of illness and burden of disease
Funding The present work received support from Janssen-Cilag Farmacêutica, Lda, as an Unrestricted Grant. Janssen-Cilag had no role in the execution of the study, including analyses and interpretation of results.
Main Author: | |
---|---|
Other Authors: | , , , , , , |
Format: | article |
Language: | eng |
Published: |
2022
|
Subjects: | |
Online Access: | http://hdl.handle.net/10362/143631 |
Country: | Portugal |
Oai: | oai:run.unl.pt:10362/143631 |